14-30694827-A-G
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_016106.4(SCFD1):c.1297A>G(p.Thr433Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0174 in 1,582,258 control chromosomes in the GnomAD database, including 303 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.013 ( 21 hom., cov: 32)
Exomes 𝑓: 0.018 ( 282 hom. )
Consequence
SCFD1
NM_016106.4 missense
NM_016106.4 missense
Scores
2
16
Clinical Significance
Conservation
PhyloP100: 5.75
Genes affected
SCFD1 (HGNC:20726): (sec1 family domain containing 1) Predicted to enable syntaxin binding activity. Involved in negative regulation of autophagosome assembly; regulation of protein transport; and response to toxic substance. Located in cis-Golgi network. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.005932212).
BP6
?
Variant 14-30694827-A-G is Benign according to our data. Variant chr14-30694827-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 981027.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=1}.
BS1
?
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0128 (1946/152296) while in subpopulation NFE AF= 0.0195 (1328/68028). AF 95% confidence interval is 0.0186. There are 21 homozygotes in gnomad4. There are 934 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
?
High AC in GnomAd at 1946 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SCFD1 | NM_016106.4 | c.1297A>G | p.Thr433Ala | missense_variant | 15/25 | ENST00000458591.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SCFD1 | ENST00000458591.7 | c.1297A>G | p.Thr433Ala | missense_variant | 15/25 | 1 | NM_016106.4 | A2 |
Frequencies
GnomAD3 genomes ? AF: 0.0128 AC: 1946AN: 152178Hom.: 21 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
1946
AN:
152178
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0128 AC: 2809AN: 219202Hom.: 31 AF XY: 0.0131 AC XY: 1556AN XY: 119078
GnomAD3 exomes
AF:
AC:
2809
AN:
219202
Hom.:
AF XY:
AC XY:
1556
AN XY:
119078
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0179 AC: 25601AN: 1429962Hom.: 282 Cov.: 31 AF XY: 0.0175 AC XY: 12464AN XY: 710768
GnomAD4 exome
AF:
AC:
25601
AN:
1429962
Hom.:
Cov.:
31
AF XY:
AC XY:
12464
AN XY:
710768
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0128 AC: 1946AN: 152296Hom.: 21 Cov.: 32 AF XY: 0.0125 AC XY: 934AN XY: 74470
GnomAD4 genome
?
AF:
AC:
1946
AN:
152296
Hom.:
Cov.:
32
AF XY:
AC XY:
934
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
82
ALSPAC
AF:
AC:
96
ESP6500AA
AF:
AC:
15
ESP6500EA
AF:
AC:
175
ExAC
?
AF:
AC:
1668
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Amyotrophic lateral sclerosis Uncertain:1
Uncertain significance, criteria provided, single submitter | case-control | UM ALS/MND Lab, University Of Malta | Sep 09, 2020 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | SCFD1: BS1, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;.;.
Vest4
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at